University of Rome La Sapienza, University Hospital
Rome, 00185, Italy
NCT Number: NCT01796847
Glycemic variability in critically ill patients is a recognized negative prognostic factor. The molecular mechanisms determining inter-patients variability in glucose metabolism during stress are not fully understood. The Phosphatase and Tensin homolog (PTEN) is known to influence glucose homeostasis by interfering in intracellular insulin signaling.
Aim of this study is to ascertain whether differential expression of PTEN in critically ill patients correlates with glycemic variability and clinical outcome.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Observational
Rome, 00185, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day 1 up to day 28
Time frame: Day 1 up to day 28
University of Roma La Sapienza
Other
Influence of PTEN on Glycemic Variability and Clinical Outcome in the Critically Ill Patient.
Acronym: GLUPTEN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03890432
Critical Illness, Deficiency Diseases
Geneva, Canton of Geneva, Switzerland
View Trial DetailsNCT05442853
Critical Illness, Diabetes Mellitus
Gainesville, Florida, United States
View Trial DetailsNCT06056167
Critical Illness, Diabetes Mellitus
Riyadh, Saudi Arabia
View Trial DetailsNCT01233726
Critical Illness, Dietary Modification
Madrid, Spain
View Trial Details